Evidence Hub

The Relationship between Serum Homocysteine Levels and Nonproliferative Diabetic Retinopathy in Type 2 Diabetes Mellitus

Hüseyin Demirci, Zafer Onaran, Nesrin Büyüktortop Gökçınar, Hüsamettin Erdamar, Nurgül Örnek

Gazi Medical Journal, 2015

68 participants

Abstract

Objective: To evaluate the relationship between serum homocysteine levels and the presence of nonproliferative diabetic retinopathy (NPDR) in type 2 Diabetes Mellitus (T2DM) patients Methods: One-hundred patients with a diagnosis of T2DM and 30 healthy control subjects whose age and sex were similar were included in this study.In diabetic patients retinopathy was assessed by ophthalmological examination.Homocysteine, fasting glucose, HbA1C, triglyceride, total cholesterol, high density lipoprotein and low density lipoprotein levels were analyzed in the blood samples in both groups.Also microalbumin levels were analyzed in 24-hour urine samples.T2DM patients were further divided into two groups according to the presence of retinopathy as patients with NPDR (Group 1, n=32) and without retinopathy (Group 2, n=68).Results: There was no statistically significant difference in the homocysteine levels between the T2DM group and the control group (13.13±4.35μmol/land 12.29±4.81μmol/l,respectively, p>0.05).Although homocysteine levels were higher in the patients with diabetic retinopathy (Group 1) than the diabetic patients without any diabetic complication (Group 2), the difference was not statistically significant (13.21±4.23mmol/land 12.96±4.60mmol/l,respectively, p>0.05).Conclusion: There was no increase in serum homocysteine levels in T2DM when there was no additional diabetic or cardiovascular complication other than NPDR.Our study, by demonstrating that serum homocysteine…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free